"Die BG Klinik Tübingen hat für Tübingen und den gesamten württembergischen Raum die Funktion einer traumatologischen Schwerpunktklinik der Maximalversorgung, in der zu jeder Tages- und Nachtzeit Verletzungen unterschiedlichster Art und Schwere behandelt werden können. Die BG Klinik Tübingen ist zusammen mit der Universitätsklinik Tübingen das überregionale Traumazentrum im TraumaNetzwerk Südwürttemberg."

During the past decade, BGU Tübingen conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BGU Tübingen" #1 sponsor was "AO Innovation Translation Center" with 3 trials, followed by "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored, "Aesculap AG" with 1 trials sponsored, "University of Zurich" with 1 trials sponsored and "Wellspect HealthCare" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BGU Tübingen" #1 collaborator was "Berufsgenossenschaftlichen Unfallklinik Tuebingen" with 1 trials as a collaborator, "EMSCI.org" with 1 trials as a collaborator, "Foundation Wings For Life" with 1 trials as a collaborator, "Heidelberg University Hospital Spinal Cord Injury Center" with 1 trials as a collaborator and "Horizon 2020 - European Commission" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "BGU Tübingen" are "Closed Fracture of Hip" (1 trials), "Distal Femur Fractures" (1 trials), "External Fixation Pin Site Infection" (1 trials), "Hip Fractures" (1 trials) and "Medial Monocompartmental Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "BGU Tübingen" in a lesser frequency.

Most popular intervention types in "BGU Tübingen" are "Device" (5 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DLS 5.0 (Dynamic locking screws)" (1 trials), "External fixator" (1 trials), "High tibial osteotomy" (1 trials), "LoFric Primo (POBE) single-use urinary catheter" (1 trials) and "LoFric Primo (PVC) single-use urinary catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "BGU Tübingen" are 7 trials for "All" genders.

Currently, there are NaN active trials in "BGU Tübingen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in BGU Tübingen, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in BGU Tübingen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".